Raising the bar for lower-risk myelodysplastic syndromes
Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone
Myelodysplastic Syndromes (MDS)
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment
Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone
Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study
Health-related quality of life (HRQoL) and vulnerability are variably affected in patients with myelodysplastic syndromes myelodysplastic syndrom
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes
Lower risk myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders whe
The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
The myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
Accurate risk prognostication is central to the management of myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-
Overview of the Management of Higher-Risk Myelodysplastic Syndromes
Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Purpose: Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A gr
Epidemiology and Pathogenesis of Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective hematopoiesis hematopoiesis: (hi-mat-uh-poy-EE-suss) The process of making blood cells in the bone marrow